Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.

ABSTRACT:

SUBMITTER: Stephens MR 

PROVIDER: S-EPMC10796159 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature